Compound ID | 1995
Synonym(s): Ilotycin
Class: Macrolide
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the bacterial 50S ribosomal subunit inhibiting translocation reaction |
| Target Pathogen: | Broad Gram-positive activity |
| Description: | Natural product from Streptomyces erythraeus; systemic and topicalapplication. |
| Institute where first reported: | Lilly Research Laboratories |
| Year first mentioned: | 1952 |
| Highest development stage: | Approved by FDA |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/12560 |
| Guide to Pharmacology: | erythromycin |
| Citations: |
|